Recurrent Gastric Cancer (DBCOND0028800)

Identifiers

Synonyms

Gastric cancer recurrent / Stomach cancer recurrent / Stomach carcinoma recurrent / Gastric carcinoma recurrent

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT01249443	Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection	Carboplatin Paclitaxel Vorinostat	treatment	1	terminated
NCT03602079	Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene	No drug interventions	treatment	1 / 2	completed
NCT01233505	Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors	Capecitabine Oxaliplatin Veliparib	treatment	1	terminated
NCT00061932	Bortezomib With or Without Irinotecan in Treating Patients With Cancer of the Gastroesophageal Junction or Stomach	Bortezomib Bortezomib D-mannitol Irinotecan	treatment	2	completed
NCT00991952	Irinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach or Gastroesophageal Junction Cancer That Cannot Be Removed By Surgery	Alvocidib Irinotecan	treatment	2	completed
NCT00064259	A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction Cancer	Cisplatin Fluorouracil	treatment	1 / 2	terminated
NCT01491217	A Study of Oraxol® in Gastric Cancer Patients	Paclitaxel	treatment	1 / 2	unknown_status
NCT00103324	S0413 Lapatinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer	Lapatinib	treatment	2	completed
NCT00028496	Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer	Sargramostim	treatment	1	completed
NCT01846520	Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers	No drug interventions	supportive_care	Not Available	completed
NCT00089362	Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors	Alvespimycin	treatment	1	completed
NCT00982592	Combination Chemotherapy With or Without Vismodegib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer	Fluorouracil Leucovorin Oxaliplatin Vismodegib	treatment	2	completed
NCT01100801	A Study of Genomic-guided 'Standard-of-care' Chemotherapy for in Advanced Gastric Cancer Patients	Cisplatin Oxaliplatin Platinum	treatment	2	unknown_status
NCT00031681	7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)	7-Hydroxystaurosporine Irinotecan	treatment	1	completed
NCT01191684	Vaccine Therapy in Treating Patients With Colorectal, Stomach, or Pancreatic Cancer	Modified vaccinia ankara	treatment	1	completed
NCT00397384	Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer	Cetuximab Erlotinib	treatment	1	completed
NCT01939275	64Cu DOTA-Trastuzumab PET/CT in Studying Patients With Gastric Cancer	No drug interventions	diagnostic	Not Available	active_not_recruiting
NCT01231399	Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer	Everolimus Fluorouracil Leucovorin Oxaliplatin	treatment	1 / 2	completed
NCT00084617	Phase II Study of Oxaliplatin, Irinotecan, and Capecitabine in Advanced Gastric/Gastroesophageal Junction Carcinoma	Capecitabine Irinotecan Oxaliplatin	treatment	2	completed
NCT00028535	Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors	Edodekin alfa Natural Killer Cell Paclitaxel Trastuzumab	treatment	1	completed
NCT00004074	Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu	Carboplatin Edodekin alfa Natural Killer Cell Paclitaxel Trastuzumab	treatment	1	completed
NCT00098527	FR901228 in Treating Patients With Refractory Stomach Cancer or Gastroesophageal Junction Cancer	Romidepsin	treatment	2	terminated
NCT00607594	Saracatinib in Treating Patients With Locally Advanced or Metastatic Stomach or Gastroesophageal Junction Cancer	Saracatinib	treatment	2	completed
NCT00087191	EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer	Motexafin lutetium	diagnostic	Not Available	terminated
NCT00068380	A Phase II Trial of STI571 in the Treatment of Metastatic Gastric Cancer	Imatinib	treatment	2	completed
NCT01705340	Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By Surgery	Lapatinib Trastuzumab	treatment	1	terminated
NCT00084604	Irinotecan, Cisplatin, and Bevacizumab in Treating Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma	Bevacizumab Cisplatin Irinotecan	treatment	2	completed
NCT01612546	Pilot Trial of CRLX101 in Treatment of Patients With Advanced or Metastatic Stomach, Gastroesophageal, or Esophageal Cancer That Cannot be Removed by Surgery	Camptothecin EP0057	treatment	2	completed